United Therapeutics
UTHR
#1103
Rank
C$28.90 B
Marketcap
C$639.12
Share price
0.38%
Change (1 day)
23.66%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2025 (TTM): C$40.10

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is C$38.81. In 2024 the company made an earnings per share (EPS) of C$36.01 an increase over its 2023 EPS that were of C$28.67.

EPS history for United Therapeutics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$40.1011.37%
2024C$36.0125.59%
2023C$28.6731.54%
2022C$21.7951.18%
2021C$14.42-9.1%
2020C$15.86-581.4%
2019C-$3.29-117.79%
2018C$18.5142.11%
2017C$13.03-40.93%
2016C$22.0513.45%
2015C$19.44104.29%
2014C$9.52100.29%
2013C$4.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$2.34-93.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$27.93-28.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$0.90-102.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$8.88-77.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
C$9.07-76.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.90-87.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
C-$8.56-122.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.86-97.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel